Cephalexin for Oral Suspension, USP, 125mg per 5mL, Rx only, 100 Tablets, Relabeled by: Bryant Ranch Prepack, Inc, Burbank, CA 91504, NDC 63629-9204-1.
Published June 12, 2024 · Recall initiated: May 10, 2024
Summary
FDA records drug Class III recall D-0536-2024, published June 12, 2024 and initiated May 10, 2024. Recalling firm: Bryant Ranch Prepack, Inc.; Status: Ongoing; Reported quantity: 156 bottles; Lot: Lot:225541, 226866, 227369, 227519, 229845, 231422, 234889, Exp: 03/31/2025. Class III means the product is not likely to cause adverse health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling: Not Elsewhere Classified: Front label states 100 Tablets instead of 100 ml and on the back label 'Each Tablet contains' instead of 'Each Bottle contains' No total dose per bottle listed should be 2.5 g'
What to do
Voluntary: Firm initiated · Letter
Get an email if CEPHALEXIN has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- CEPHALEXIN
- Manufacturer
- Bryant Ranch Prepack, Inc.
- Distributor
- Nationwide in the USA
- Lot
- Lot:225541, 226866, 227369, 227519, 229845, 231422, 234889, Exp: 03/31/2025
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDACephalexin for Oral Suspension, USP, 125 mg per 5 mL, 100 mL (when mixed), Rx Only, Manufactured by: AlkemJune 18, 2025
- FDACephalexin for Oral Suspension, USP, 125 mg per 5 mL, 200 mL (when mixed), Rx Only, Manufactured by: AlkemJune 18, 2025
- FDACephalexin for Oral Suspension, USP, 250mg per 5mL, Rx only, 100mL (when mixed), Each contains cephalexinJune 12, 2024
- FDACephalexin for Oral Suspension, USP, 125mg per 5mL, Rx only, 200mL (when mixed), Each contains: cephalexinJune 12, 2024
- FDARizatriptan Benzoate Orally Disintegrating Tablets, USP 10mg, 18 (3 x 6) Unit-Dose Tablets, Manufactured for:June 12, 2024
- FDARizatriptan Benzoate Orally Disintegrating Tablets, USP 5mg, 18 (3 x 6) Unit-Dose Tablets, Manufactured for:June 12, 2024
Questions about this recall
Was Cephalexin for Oral Suspension, USP, 125mg per 5mL, Rx only, 100 Tablets, Relabeled by: Bryant Ranch Prepack, Inc, Burbank, CA 91504, NDC 63629-9204-1. recalled?
Yes. FDA published recall D-0536-2024 on June 12, 2024. Reported hazard: Labeling: Not Elsewhere Classified: Front label states 100 Tablets instead of 100 ml and on the back label 'Each Tablet contains' instead of 'Each Bottle contains' No total dose per bottle listed should be 2.5 g'
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: CEPHALEXIN.